ACE2 and COVID-19: Recent investigations through full autopsy or minimally invasive autopsy of COVID-19 decedents by us and other laboratories [6–16], revealed that SARS-CoV-2 hijacked angiotensin converting enzyme 2 (ACE2) for entry into target cells [17] to cause severe pathologic changes in the lungs and multiple extrapulmonary organs/tissues.